Genesis IBRC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194N01016
  • NSEID:
  • BSEID: 514336
INR
90.65
0.00 (0.00%)
BSENSE

Dec 12

BSE+NSE Vol: 108

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGenesis IBRC VS Pharmaceuticals & Biotechnology
 
1D
0%
0.53%
1W
-18.48%
-0.52%
1M
-49.99%
0.95%
YTD
%
9.12%
1Y
444.77%
4.89%
3Y
747.2%
37.24%
5Y
1115.15%
84.97%
10Y
488.64%
240.47%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
86.79%
0%
86.79%
6 Months
0%
0%
0.0%
1 Year
444.77%
0%
444.77%
2 Years
831.65%
0%
831.65%
3 Years
747.2%
0%
747.2%
4 Years
1060.69%
0%
1060.69%
5 Years
1115.15%
0%
1115.15%

Genesis IBRC for the last several years.

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available